We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Talk by Dr. Madhvi Joshi on ‘Learnings from Past: Extending Environmental Surveillance beyond COVID’
We were glad to host Dr. Madhvi Joshi, Scientist and Joint Director,... read more
On XE Varaiant of Omicron
COVID mutant 'XE': TIGS Director Rakesh Mishra urges citizens not to panic,... read more
PhD Admissions – List of shortlisted candidates
List of shortlisted candidates for TIGS PhD admissions (Jan 2023) via AcSIR... read more
Wastewater study detects a large, silent wave in Bengaluru
The XBB.1.16 Omicron recombinant first detected in India on December 25, 2022... read more
Latest publication: One Health Index Calculator for India
We are excited to share our recent publication where researchers have developed... read more
COVID-19 is airborne; Masks still essential to avoid the spread of virus, Collaborative Study reveals
In a collaborative study, it is found that, novel Coronavirus is airborne... read more
Interview with Dr.Rakesh Mishra on IndiaScience TV
How dangerous is the new XE variant of Covid-19? Is the Covid... read more
DBT/Wellcome Trust India Alliance Early Career Fellowship to Dr. Shivranjani Moharir
We are pleased to announce that Dr. Shivranjani Moharir, Senior Scientist, TIGS... read more
Our research is aimed at making treatment for rare genetic diseases affordable
In an exclusive interview to Gunjan Sharma from the HealthPost, Dr. Rakesh... read more
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more

